750
Views
25
CrossRef citations to date
0
Altmetric
Review

Assessing methods of measuring medication adherence in chronically ill children–a narrative review

, , &
Pages 1175-1189 | Published online: 22 Jul 2019

References

  • Van Cleave J, Gortmaker SL, Perrin JM. Dynamics of obesity and chronic health conditions among children and youth. Jama. 2010;303(7):623–630. doi:10.1001/jama.2010.10420159870
  • Epping-Jordan J, Bengoa R, Kawar R, Sabaté E. The challenge of chronic conditions: WHO responds. Bmj. 2001;323(7319):947–948. doi:10.1136/bmj.323.7319.94711679371
  • DeSevo G, Klootwyk J. Pharmacologic issues in management of chronic disease. Prim Care. 2012;39(2):345–362. doi:10.1016/j.pop.2012.03.00722608870
  • DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811. doi:10.1097/01.MLR.0000024612.61915.2D12218770
  • El-Rachidi S, LaRochelle JM, Morgan JA. Pharmacists and Pediatric Medication Adherence: bridging the Gap. Hosp Pharm. 2017;52(2):124–131. doi:10.1310/hpj5202-12428321139
  • Santer M, Ring N,Yardley L, et al. Treatment non-adherence in pediatric long-term medical conditions: systematic review and synthesis of qualitative studies of caregivers’ views. BMC Pediatr. 2014;14:63. doi:10.1186/1471-2431-14-8224593304
  • De Civita M, Dobkin PL. Pediatric adherence as a multidimensional and dynamic construct, involving a triadic partnership. J Pediatr Psychol. 2004;29(3):157–169.15131134
  • Leonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol. 2004;19(3):151–180. doi:10.1002/hup.57915079851
  • Paterson, D.L., Swindells S., Mohr J., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.10877736
  • Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi:10.2147/RMHP.S1980124591853
  • Matsui DM. Drug compliance in pediatrics: clinical and research issues. Pediatr Clin North Am. 1997;44(1):1–14.9057780
  • Dawood OT, Izham M, Ibrahim M, Palaian S. Medication compliance among children. World J Pediatr. 2010;6(3):200–202. doi:10.1007/s12519-010-0218-820706818
  • World Health Organization. Adherence to long-term therapies - evidence for action. Available from: http://apps.who.int/medicinedocs/en/d/Js4883e/. Accessed July 01, 2017.
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;1–12. doi:10.1155/2015/217047
  • Düsing R, Mengden T. Compliance with drug therapy—new answers to an old question. Nephrol Dialysis Transplant. 2001;16:1317–1321. doi:10.1093/ndt/16.7.1317
  • Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1–10. doi:10.3904/kjim.2009.24.1.119270474
  • Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol. 2008;33(9):916–936. doi:10.1093/jpepsy/jsm06417846042
  • Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77(3):427–445. doi:10.1111/bcp.1219423803249
  • Jentzsch NS, Camargos PAM. Methods of assessing adherence to inhaled corticosteroid therapy in children and adolescents: adherence rates and their implications for clinical practice. J Bras Pneumol. 2008;34(8):614–621.18797747
  • Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–482. doi:10.1007/s13142-015-0315-226622919
  • Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. 2010;28(12):1097–1107. doi:10.2165/11537400-000000000-0000021080735
  • Kyngas HA, Skaar-Chandler CA, Duffy ME. The development of an instrument to measure the compliance of adolescents with a chronic disease. J Adv Nurs. 2000;32(6):1499–1506.11136419
  • Johannessen SI, Landmark CJ. Value of therapeutic drug monitoring in epilepsy. Expert Rev Neurother. 2008;8(6):929–939. doi:10.1586/14737175.8.6.92918505358
  • Van Rossum AMC, Bergshoeff AS, Fraaij PL, et al. Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002;21(8):743–747. doi:10.1097/01.inf.0000023962.00726.a912192162
  • MacLeoad S. Therapeutic drug monitoring in pediatrics: how do children differ? Ther Drug Monit. 2010;32(3):253–256. doi:10.1097/FTD.0b013e3181dd51ef20463632
  • Mahmood I. Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings. Clin Pharmacokinet. 2014;53(4):327–346. doi:10.1007/s40262-014-0134-524515100
  • Walson PD. Role of therapeutic drug monitoring (TDM) in pediatric anti-convulsant drug dosing. Brain Develop. 1994;16(1):23–26. doi:10.1016/0387-7604(94)90108-2
  • Fassler D, Wallace N. Childrens Fear of Needles. Clin Pediatr (Phila). 1982;21(1):59–60. doi:10.1177/000992288202100112
  • Deep A, Kumar P, Kumar A, Thakkar AS. Dry blood spot technique: a review. Intl J Pharm Sci Rev Res. 2012;15(2):90–94.
  • Martial LC, Aarnoutse RE, Schreuder MF, et al. Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children. PLoS One. 2016;11(12):e0167433. doi:10.1371/journal.pone.016743327941974
  • Lacy P, Lee JL, Vethanayagam D. Sputum analysis in diagnosis and management of obstructive airway diseases. Ther Clin Risk Manag. 2005;1(3):169–179.18360557
  • Lena SM, Hutchins P, Wood CB, Turner P. Salivary theophylline estimation in the management of asthma in children. Postgrad Med J. 1980;56(652):85–87. doi:10.1136/pgmj.56.652.857393801
  • Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet. 1999;36(6):453–470. doi:10.2165/00003088-199936060-0000610427469
  • Prasitsuebsai W, Kerr SJ, Truong KH, et al. Using lopinavir concentrations in hair samples to assess treatment outcomes on second-line regimens among asian children. AIDS Res Hum Retroviruses. 2015;31(10):1009–1014. doi:10.1089/AID.2015.011126200586
  • Guillet R, Kwon JM, Chen S, McDermott MP. Urine phenobarbital drug screening: potential use for compliance assessment in neonates. J Child Neurol. 2012;27(2):200–203. doi:10.1177/088307381141666521954428
  • Parameswaran K, Leigh R, Hargreave FE. Sputum eosinophil count to assess compliance with corticosteroid therapy in asthma. J Allergy Clin Immunol. 1999;104(2 I):502–503.10452780
  • Miraglia Del Giudice M, Marseglia GL, Leonardi S, et al. Fractional exhaled nitric oxide measurements in rhinitis and asthma in children. Int. J. Immunopathol. Pharmacol. 2011;24(4 Suppl):29–32.
  • Vijverberg SJH, Koster ES. Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy‐based study. Pediatr Allergy and Immunol. 2012;23(6):529–536. doi:10.1111/j.1399-3038.2012.01279.x22624949
  • Olivieri NF, Matsui D, Hermann C, Koren G. Compliance assessed by the medication event monitoring system. Arch Dis Child. 1991;66(12):1399–1402. doi:10.1136/adc.66.12.13991776885
  • Matsui D, Hermann C, Braudo M, Ito S, Olivieri N, Koren G. Clinical use of the medication event monitoring system: a new window into pediatric compliance. Clin Pharmacol Ther. 1992;52(1):102–103.1623684
  • Ingerski LM, Hente EA, Modi AC, Hommel KA. Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. J Pediatr. 2011;159(4):528–534. doi:10.1016/j.jpeds.2011.05.01821722917
  • Ailinger RL, Black PL, Lima-Garcia N. Use of electronic monitoring in clinical nursing research. Clin Nurs Res. 2008;17(2):89–97. doi:10.1177/105477380831694118387881
  • Vasbinder EC, Janssens HM, Rutten-van Mölken MPMH, et al. e-monitoring of asthma therapy to improve compliance in children using a real-time medication monitoring system (RTMM): the e-MATIC study protocol. BMC Med Inform Decis Mak. 2013;13:38. doi:10.1186/1472-6947-13-3823514242
  • Vasbinder E, Dahhan N, Wolf B, et al. The association of ethnicity with electronically measured adherence to inhaled corticosteroids in children. Eur J Clin Pharmacol. 2013;69(3):683–690. doi:10.1007/s00228-012-1380-922955894
  • Haberer JE, Kiwanuka J, Nansera D, et al. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. Aids. 2013;27(13):2166–2168. doi:10.1097/QAD.0b013e328363b53f23751260
  • Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc. 2003;53(2):172–181. doi:10.1331/JAPhA.2013.12202
  • Vervloet M, Linn AJ, van Weert JCM, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19(5):696–704. doi:10.1136/amiajnl-2011-00074822534082
  • Riekert KA, Rand CS. Electronic monitoring of medication adherence: when is high-tech best? J Clin Psychol Med Settings. 2002;9(1):25–34. doi:10.1023/A:1014131928789
  • Grimes DE, Andrade RA, Niemeyer CR, Grimes RM. Measurement issues in using pharmacy records to calculate adherence to antiretroviral drugs. HIV Clin Trials. 2013;14(2):68–74. doi:10.1310/hct1402-6823611827
  • Rijcken CAW, Tobi H, Vergouwen ACM, de Jong-van den Berg LTW. Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients’ compliance by using computerised pharmacy data. Pharmacoepidemiol Drug Saf. 2004;13(6):365–370. doi:10.1002/pds.95115170765
  • Vink NM, Klungel OH, Stolk RP, Denig P. Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf. 2009;18(2):159–165. doi:10.1002/pds.169819109809
  • Wilke T, Groth A, Mueller S, et al. How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus. Eur J Health Econ. 2013;14(3):551–568. doi:10.1007/s10198-012-0410-y22815097
  • Rickles NM, Svarstad BL. Relationships between multiple self-reported nonadherence measures and pharmacy records. Res Social Admin Pharm. 2007;3(4):363–377. doi:10.1016/j.sapharm.2006.11.001
  • Mudd K, Bollinger ME, Hsu VD, Donithan M, Butz A. Pharmacy fill patterns in young urban children with persistent asthma. J Asthma. 2006;43(8):597–600. doi:10.1080/0277090060087853717050224
  • McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011;52(4):493–506. doi:10.1093/cid/ciq16721245156
  • Mudd KE, Bollinger ME, Hsu VD, Manning A, Tsoukleris MG, Butz AM. Concordance of Medicaid and pharmacy record data in inner-city children with asthma. Contemp Clin Trials. 2008;29(1):13–20. doi:10.1016/j.cct.2007.05.00217574930
  • Martinez CER, Sossa MP, Rand CS. Validation of a questionnaire for assessing adherence to metered-dose inhaler use in asthmatic children. Pediatr Asthma Allergy Immunol. 2007;20(4):243–253. doi:10.1089/pai.2007.001
  • Charach A, Gajaria A, Skyba A, Chen S. Documenting adherence to psychostimulants in children with ADHD. J Can Acad Child Adolesc Psychiatry. 2008;17(3):131–136.18769643
  • Modi AC, Monahan S, Daniels D, Glauser TA. Development and validation of the Pediatric Epilepsy Medication Self-Management Questionnaire. Epilepsy Behav. 2010;18(1–2):94–99. doi:10.1016/j.yebeh.2010.03.00920452831
  • Heo M, Kim N, Faith MS. Statistical power as a function of Cronbach alpha of instrument questionnaire items. BMC Med Res Methodol. 2015;15(86). doi:10.1186/s12874-015-0092-0
  • Manias E, Williams A. Medication adherence in people of culturally and linguistically diverse backgrounds: a meta-analysis. Ann Pharmacother. 2010;44(6):964–982. doi:10.1345/aph.1M57220442356
  • Diaz E, Woods SW, Rosenheck RA. Effects of ethnicity on psychotropic medications adherence. Community Ment Health J. 2005;41(5):521–537. doi:10.1007/s10597-005-6359-x16142536
  • Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs. 1995;49(3):321–327. doi:10.2165/00003495-199549030-00001
  • Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatry. 2012;2(5):74–82. doi:10.5498/wjp.v2.i5.7424175171
  • Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014;5:43–62. doi:10.2147/PROM.S4273525061342
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/21704726539470
  • Quittner AL, Espelage DL, levers-Landis C, Drotar D. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information. J Clin Psychol Med Settings. 2000;7(1):41–54. doi:10.1023/A:1009545319673
  • Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–550. doi:10.1001/archinte.167.6.54017389285
  • Haberer JE, Cook A, Walker AS, et al. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV Nondisclosure, and paradoxical income effects. PLoS One. 2011;6(4):e18505. doi:10.1371/journal.pone.001850521533031
  • Dolezal C, Mellins C, Brackis-Cott E, Abrams EJ. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003;28(5):355–361.12808012
  • Kendrick R, Bayne JRD. Compliance with prescribed medication by elderly patients. Can Med Assoc J. 1982;127(10):961–962.7139444
  • Kalichman SC, Amaral CM, Stearns H, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007;22(7):1003–1006. doi:10.1007/s11606-007-0171-y17390095
  • Tiggelman D, Van de Ven MOM, Van Schayck OCP, Engels RCME. Longitudinal associations between asthma control, medication adherence, and quality of life among adolescents: results from a cross-lagged analysis. Qual Life Res. 2015;24(9):2067–2074. doi:10.1007/s11136-015-0945-325715944
  • Cohen JL, Mann DM, Wisnivesky JP, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the medication adherence report scale for asthma. Ann Allergy, Asthma Immunol. 2009;103:325–331. doi:10.1016/S1081-1206(10)60532-719852197
  • Garcia-Marcos PW, Brand PLP, Kaptein AA, Klok T. Is the MARS questionnaire a reliable measure of medication adherence in childhood asthma? J Asthma. 2016;53(10):1085–1089. doi:10.1080/02770903.2016.118069927177241
  • McQuaid EL, Walders N, Kopel SJ, Fritz GK, Klinnert MD. Pediatric asthma management in the family context: the family asthma management system scale. J Pediatr Psychol. 2005;30(6):492–502. doi:10.1093/jpepsy/jsi07416055487
  • Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquired Immune Defic Syndr. 2003;33(2):211–218. doi:10.1097/00126334-200306010-0001612794557
  • Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109(4):e61. doi:10.1542/peds.109.4.e6111927734
  • Lewin AB, LaGreca AM, Geffken GR, et al. Validity and reliability of an adolescent and parent rating scale of type 1 diabetes adherence behaviors: the Self-Care Inventory (SCI). J Pediatr Psychol. 2009;34(9):999–1007. doi:10.1093/jpepsy/jsp03219423660
  • Lewin AB, Storch EA, Williams LB, Duke DC, Silverstein JH, Geffken GR. Brief report: normative data on a structured interview for diabetes adherence in childhood. J Pediatr Psychol. 2010;35(2):177–182. doi:10.1093/jpepsy/jsp05519589854
  • Harris MA, Wysocki T, Sadler MICH, et al. Validation of a structured interview for the assessment of diabetes self-management. Diabetes Care. 2000;23(9):1301–1304.10977022
  • Markowitz JT, Laffel LM, Volkening LK, et al. Validation of an abbreviated adherence measure for young people with Type1 diabetes. Diabet Med. 2011;28(9):1113–1117.21843307